Skip to content

Strides Pharma sinks after subsidiary plans to divest manufacturing plant

The manufacturing unit has a potential for future expansion up to a further 20,000 litres of biologics drug substance manufacturing capacity.

Read More

​ The manufacturing unit has a potential for future expansion up to a further 20,000 litres of biologics drug substance manufacturing capacity. The manufacturing unit has a potential for future expansion up to a further 20,000 litres of biologics drug substance manufacturing capacity.  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish